- Investing Ideas
- /
- Global Pharmaceuticals & Biotech All Weather Stocks
Global Pharmaceuticals & Biotech All Weather Stocks
UPDATED Feb 20, 2024
Defensive mid-caps and large-caps in descending order of expected ROE in three years.
48 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AMGNAmgen | US$283.51 | -2.3% | 20.1% | US$151.9b | US$303.65 | PE22.6x | E9.2% | 3.2% | ||
| ABBVAbbVie | US$175.75 | 0.8% | 16.6% | US$310.3b | US$178.46 | PE63.8x | E23.1% | 3.5% | ||
| OGNOrganon | US$18.49 | 13.0% | -31.1% | US$4.7b | US$21.67 | PE4.6x | E3.8% | 6.1% | ||
| MRKMerck | US$127.37 | 1.2% | 16.7% | US$322.8b | US$133.65 | PE884.3x | E25.0% | 2.4% | ||
| 300009Anhui Anke Biotechnology (Group) | CN¥9.76 | -2.5% | -15.9% | CN¥16.3b | CN¥19.54 | PE21.4x | E21.9% | 2.6% | ||
| BMYBristol-Myers Squibb | US$49.86 | 2.0% | -30.1% | US$100.8b | US$58.15 | PE12.6x | E7.6% | 4.8% | ||
| ROGRoche Holding | CHF232.20 | 1.6% | -17.6% | CHF186.7b | CHF286.28 | PE16.1x | E8.4% | 4.1% | ||
| NOVNNovartis | CHF90.77 | 3.1% | 12.4% | CHF185.5b | CHF96.64 | PE24.6x | E9.9% | 3.6% | ||
| JNJJohnson & Johnson | US$157.86 | 1.4% | 0.05% | US$380.2b | US$174.55 | PE28.5x | E9.3% | 3.0% | ||
| GSKGSK | UK£16.78 | 2.2% | 13.2% | UK£68.1b | UK£19.95 | PE13.8x | E9.2% | 3.5% | ||
| ORNBVOrion Oyj | €38.94 | -2.8% | -15.7% | €5.5b | €41.30 | PE25.2x | E13.7% | 4.2% | ||
| GILDGilead Sciences | US$72.04 | -1.4% | -13.7% | US$89.8b | US$88.16 | PE15.8x | E6.7% | 4.3% | ||
| AZNAstraZeneca | UK£102.04 | 6.3% | -11.8% | UK£158.2b | UK£128.06 | PE33.5x | E16.7% | 2.2% | ||
| RPRXRoyalty Pharma | US$30.30 | 3.4% | -18.4% | US$18.0b | US$45.11 | PE11.9x | E5.9% | 2.8% | ||
| 739Apeloa PharmaceuticalLtd | CN¥13.72 | 1.6% | -41.9% | CN¥16.0b | CN¥23.46 | PE13.6x | E20.9% | 2.2% | ||
| DMPDermapharm Holding | €37.02 | -4.2% | -1.1% | €2.0b | €59.40 | PE21x | E17.3% | 2.8% | ||
| RICHTERRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt | Ft9,795.00 | 1.9% | 25.7% | Ft1.8t | Ft11,019.44 | PE22.2x | E32.8% | 4.0% | ||
| 600750Jiang Zhong PharmaceuticalLtd | CN¥24.16 | 6.1% | 49.7% | CN¥15.1b | CN¥30.00 | PE22.1x | E14.3% | 5.2% | ||
| 867China Medical System Holdings | HK$12.26 | 6.4% | -1.8% | HK$30.1b | HK$18.23 | PE8.2x | E8.6% | 5.0% | ||
| HIKHikma Pharmaceuticals | UK£19.85 | 1.3% | 11.6% | UK£4.4b | UK£22.20 | PE37.9x | E18.4% | 2.5% | ||
| PFEPfizer | US$27.59 | 1.8% | -34.9% | US$155.8b | US$33.00 | PE73x | E19.1% | 6.1% | ||
| HYPE3Hypera | R$32.72 | 6.1% | -25.3% | R$20.7b | R$43.37 | PE11.7x | E12.3% | 3.8% | ||
| 600566Hubei Jumpcan Pharmaceutical | CN¥35.55 | 3.7% | 21.8% | CN¥32.8b | CN¥42.71 | PE13x | E10.0% | 2.5% | ||
| 2603Shijiazhuang Yiling Pharmaceutical | CN¥21.31 | 2.7% | -32.3% | CN¥35.6b | CN¥27.02 | PE13.2x | E7.9% | 2.3% |